Pacific Biosciences Of California reported $734.58M in Equity Capital and Reserves for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Accelerate Diagnostics AXDX:US -56776000 21.7M
Agilent A:US $ 5122M 32M
Bruker BRKR:US $ 1017M 53.5M
Danaher DHR:US $ 46356M 1189M
Fluidigm FLDM:US $ 22.11M 72.48M
General Electric GE:US $ 39005M 1305M
Illumina ILMN:US $ 10895M 155M
Myriad Genetics MYGN:US $ 950.1M 17.7M
Nanostring Technologies NSTG:US $ 145.3M 31.66M
Pacific Biosciences Of California PACB:US $ 734.58M 56.41M
Perkinelmer PKI:US $ 7186.34M 45.1M
Quidel QDEL:US $ 2414.92M 485.56M
Thermo Fisher Scientific TMO:US $ 40956M 163M
Waters WAT:US $ 374.94M 7.38M